Sanofi Consumer Healthcare India Limited (SANOFICONR) Q2 2024 earnings summary

Executive summary

• Unaudited financial results for the quarter and half year ended June 30, 2024, have been reviewed and approved by the Board on August 13, 2024.

• Results reflect the demerger of the Consumer Healthcare business from Sanofi India Limited, effective June 1, 2024, with financials drawn from May 10, 2023.

Financial highlights

• Revenue from operations for Q2 2024 was ₹1,644 million; half-year revenue was ₹3,756 million.

• Profit before tax for the half year ended June 30, 2024, was ₹1,228 million, up from ₹345 million for the comparable prior period.

• Net profit for the half year was ₹917 million, with total comprehensive income at ₹917 million.

• Basic and diluted EPS for the half year was ₹39.82.

Outlook and guidance

• Results for the current and previous periods are not directly comparable due to the demerger and seasonality, as well as a voluntary product recall.